Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06053164
PHASE2

Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

Sponsor: University of Alberta

View on ClinicalTrials.gov

Summary

The investigators plan to conduct a study to find out if giving portable oxygen therapy (during physical activity) to patients with interstitial lung disease will improve quality of life, exercise tolerance, shortness of breath, and blood vessel function. Oxygen will be provided for a period of 8 weeks. Additionally, the investigators plan to investigate if it is helpful to deliver individualized support when providing oxygen therapy, through check-in phone calls with a respiratory therapist and by providing additional educational material.

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2025-07-01

Completion Date

2026-09-01

Last Updated

2026-04-09

Healthy Volunteers

No

Interventions

DRUG

Exertional Oxygen

Use of a portable oxygen concentrator for exertional activities lasting \>2 minutes

BEHAVIORAL

Education and Support

Participants will receive disease-specific educational material (Living Well with Pulmonary Fibrosis: Oxygen), and will have scheduled phone appointments with a certified respiratory educator after 1, 3, and 5 weeks of oxygen therapy in order to address individual barriers to oxygen use and facilitate the optimal use of portable oxygen.

Locations (1)

Clinical Physiology Laboratory

Edmonton, Alberta, Canada